Top Markets
Coin of the day
Avidity Biosciences Inc Avidity Biosciences Inc

Avidity Biosciences Inc

RNAM
Rang in Aktien #2179
Avidity Biosciences, Inc. is at the forefront of developing a novel class of... Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
Aktienkurs
$71.34
Zuletzt synchronisiert: 2026-03-03
Marktkapitalisierung
$9.84B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-
Land
US
Handel Avidity Biosciences Inc (RNAM)

Kategorie

Aktien-Split-Historie für Avidity Biosciences Inc (RNAM)
Die Aktie Avidity Biosciences Inc (Symbol: RNAM) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 25, 2026 statt.
Eine RNAM-Aktie, die vor dem Aug 25, 2026 gekauft wurde, entspricht heute 0 RNAM-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH